Immune therapy for autoimmune diseases

Science
Lawrence Steinman

Abstract

Our increasing understanding of the pathophysiology of autoimmune disease has revealed a number of checkpoints that can be targeted with immune therapy, including key mediators of lymphocyte adhesion and migration, destructive cytokines involved in tissue damage, and the complex of molecules critical in the presentation of self-antigen and the activation of autoaggressive T lymphocytes. In many organ-specific autoimmune diseases, the identity of the molecules attacked by T cells and autoantibodies is known and attempts are under way to tolerize the immune system with a high level of specificity to these targets.

References

Jul 1, 1990·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L Steinman, R Mantegazza
Jul 1, 1994·Annals of Neurology·R ZakD Labar
Aug 1, 1995·Immunopharmacology and Immunotoxicology·C S ConstantinescuA Rostami
Apr 5, 1996·Science·E C Butcher, L J Picker
Jul 31, 1998·The New England Journal of Medicine·C ConfavreuxT Moreau
Dec 30, 1999·International Reviews of Immunology·M Sela
Mar 13, 2001·Annual Review of Immunology·J F Bach, L Chatenoud
May 30, 2001·Lancet·G ComiUNKNOWN Early Treatment of Multiple Sclerosis Study Group
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·P J RuizL Steinman
May 31, 2002·The New England Journal of Medicine·Kevan C HeroldJeffrey A Bluestone
Aug 16, 2002·Transplant Immunology·Monika Ostensen, Peter M Villiger
Aug 31, 2002·Diabetes/metabolism Research and Reviews·Paolo Pozzilli
Jan 3, 2003·The New England Journal of Medicine·David H MillerUNKNOWN International Natalizumab Multiple Sclerosis Trial Group
Jan 3, 2003·The New England Journal of Medicine·Subrata GhoshUNKNOWN Natalizumab Pan-European Study Group
Jan 3, 2003·The New England Journal of Medicine·Ulrich H von Andrian, Britta Engelhardt
Jul 10, 2003·Autoimmunity Reviews·C Asseman, M von Herrath
Jul 10, 2003·Autoimmunity Reviews·Anthony J SlavinC Garrison Fathman
Aug 12, 2003·Nature Biotechnology·William H RobinsonLawrence Steinman
Sep 12, 2003·Trends in Immunology·Rosetta PedottiStephen J Galli
Oct 17, 2003·The New England Journal of Medicine·Robert B Darnell, Jerome B Posner

❮ Previous
Next ❯

Citations

Jun 7, 2008·Modern Rheumatology·Masao NawataYoshiya Tanaka
Jun 3, 2005·Nature·Marc Feldmann, Lawrence Steinman
Aug 26, 2006·Nature Clinical Practice. Neurology·Martin S WeberScott S Zamvil
Jan 31, 2006·Nature Immunology·Morgan HuseMark M Davis
Apr 7, 2011·Nature Reviews. Rheumatology·Salvatore AlbaniBerent Prakken
Nov 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·Peter TernessGerhard Opelz
Nov 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Lawrence Steinman
Apr 20, 2005·Current Opinion in Rheumatology·John J O'SheaPaul Changelian
Aug 12, 2005·Current Opinion in Rheumatology·Eva C KoffemanSalvatore Albani
Dec 16, 2006·Annals of the Rheumatic Diseases·Wilco de JagerBerent J Prakken
Sep 22, 2006·Annual Review of Medicine·E William St ClairJeffrey Bluestone
Jan 29, 2008·Blood·Li TianCarl G Gahmberg
Jun 24, 2011·The Journal of Clinical Endocrinology and Metabolism·Samantha KimballJodie M Burton
Oct 27, 2012·Advanced Drug Delivery Reviews·Kwang-Chul KwonHenry Daniell
Jun 15, 2013·Oxidative Medicine and Cellular Longevity·Costanza SavinoMarco Giorgio
May 14, 2014·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·M Tariq Bhatti, Jonathan J Dutton
Apr 14, 2006·Journal of Endocrinological Investigation·C AlviggiG Matarese
Dec 24, 2005·Nature Chemical Biology·Sarah G Hymowitz, Avi Ashkenazi
May 7, 2008·Expert Review of Neurotherapeutics·Maurizio BifulcoGiuseppe Marasco
Mar 1, 2006·Expert Review of Clinical Immunology·Bethan Lang, Nick Willcox
Jul 1, 2007·Expert Review of Clinical Immunology·Andreas M Hohlbaum, Arne Skerra
Jul 16, 2005·Expert Opinion on Biological Therapy·Sonia Berrih-AkninMiriam C Souroujon
Oct 17, 2006·Expert Opinion on Investigational Drugs·Mai ZhangRobin L Thurmond
Sep 29, 2009·Trends in Immunology·Helgi ValdimarssonAndrew Johnston
Mar 2, 2012·The Journal of Investigative Dermatology·Monika EttingerJohann W Bauer
Jan 19, 2005·The Journal of Investigative Dermatology·Delphine J Lee, Robert L Modlin
Feb 24, 2015·Cytokine·Dusanka S SkundricHarley Y Tse
Apr 22, 2009·Experimental Dermatology·Manfred Kneilling, Martin Röcken
May 9, 2009·European Journal of Immunology·Patrick C RaemerCarsten Watzl
Sep 14, 2007·Pigment Cell Research·Wiete Westerhof, Marco d'Ischia
Apr 16, 2008·Journal of Internal Medicine·J Nilsson, G K Hansson
Dec 31, 2005·Arthritis and Rheumatism·Salvatore Albani, Berent Prakken
Jan 9, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·B Noël

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.